tiprankstipranks
Advertisement
Advertisement
Validating WaferiX and Fully Funding Wafermine: Multiple Monetisation Pathways Support Buy Rating on iX Biopharma
PremiumRatingsValidating WaferiX and Fully Funding Wafermine: Multiple Monetisation Pathways Support Buy Rating on iX Biopharma
2M ago
iX Biopharma Wins US$41 Million U.S. Contract to Advance Wafermine Pain Therapy
Premium
Company Announcements
iX Biopharma Wins US$41 Million U.S. Contract to Advance Wafermine Pain Therapy
4M ago
iX Biopharma Wins US$41 Million U.S. Defense Contract for Non-Opioid Pain Drug
Premium
Company Announcements
iX Biopharma Wins US$41 Million U.S. Defense Contract for Non-Opioid Pain Drug
4M ago
iX Biopharma Partners with Orion to Launch WaferiX® in U.S.
PremiumCompany AnnouncementsiX Biopharma Partners with Orion to Launch WaferiX® in U.S.
7M ago
iX Biopharma Secures S$6.7 Million for U.S. Market Expansion
Premium
Company Announcements
iX Biopharma Secures S$6.7 Million for U.S. Market Expansion
7M ago
iX Biopharma to Raise S$5 Million via Share Placement
Premium
Company Announcements
iX Biopharma to Raise S$5 Million via Share Placement
8M ago
iX Biopharma Achieves 39% Revenue Growth and Improves Operational Efficiency in 1H25
PremiumCompany AnnouncementsiX Biopharma Achieves 39% Revenue Growth and Improves Operational Efficiency in 1H25
1y ago
iX Biopharma’s iXB 401: A Breakthrough in Drug Delivery
Premium
Company Announcements
iX Biopharma’s iXB 401: A Breakthrough in Drug Delivery
2y ago
iX Biopharma Unveils Growth Plans at AGM
Premium
Company Announcements
iX Biopharma Unveils Growth Plans at AGM
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100